A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT04176588 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderately to Severely Active Ulcerative Colitis

Interventions

DRUG: Etrasimod
DRUG: Placebo

Sponsor

Everstar Therapeutics Limited